Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.

Monleón D, Morales JM, Gonzalez-Segura A, Gonzalez-Darder JM, Gil-Benso R, Cerdá-Nicolás M, López-Ginés C.

Cancer Res. 2010 Nov 1;70(21):8426-34. doi: 10.1158/0008-5472.CAN-10-1498. Epub 2010 Sep 21.

2.

Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Gonçalves JM, Santos-Briz A, Morales F, Orfao A.

J Mol Diagn. 2004 Nov;6(4):316-25.

3.

Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.

Serna E, Morales JM, Mata M, Gonzalez-Darder J, San Miguel T, Gil-Benso R, Lopez-Gines C, Cerda-Nicolas M, Monleon D.

PLoS One. 2013 Jun 28;8(6):e67291. doi: 10.1371/journal.pone.0067291. Print 2013.

4.

Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.

Monleón D, Morales JM, Gonzalez-Darder J, Talamantes F, Cortés O, Gil-Benso R, López-Ginés C, Cerdá-Nicolás M, Celda B.

J Proteome Res. 2008 Jul;7(7):2882-8. doi: 10.1021/pr800110a. Epub 2008 May 29.

PMID:
18507434
5.

Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?

Pfisterer WK, Hendricks WP, Scheck AC, Nieman RA, Birkner TH, Krampla WW, Preul MC.

Neurosurgery. 2007 Nov;61(5):1048-59; discussion 1060-1.

PMID:
18091281
6.

Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.

Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC.

J Neurooncol. 2008 Mar;87(1):43-50. Epub 2007 Nov 30.

PMID:
18060363
7.

Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.

Arslantas A, Artan S, Oner U, Durmaz R, Müslümanoğlu H, Atasoy MA, Başaran N, Tel E.

Acta Neurol Belg. 2002 Jun;102(2):53-62.

PMID:
12161900
8.

Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.

Maillo A, Orfao A, Espinosa AB, Sayagués JM, Merino M, Sousa P, Lara M, Tabernero MD.

Neuro Oncol. 2007 Oct;9(4):438-46. Epub 2007 Aug 17.

9.

Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.

Trinkaus M, Vranic A, Dolenc VV, Lah TT.

Int J Biol Markers. 2005 Jan-Mar;20(1):50-9.

PMID:
15832773
10.

Chromosomal and genetic aberrations differ with meningioma subtype.

Wada K, Maruno M, Suzuki T, Kagawa N, Hashiba T, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T.

Brain Tumor Pathol. 2004;21(3):127-33.

PMID:
15696974
11.

Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors.

Zattara-Cannoni H, Gambarelli D, Dufour H, Figarella D, Vollot F, Grisoli F, Vagner-Capodano AM.

Ann Genet. 1998;41(3):164-75.

PMID:
9833072
12.

Cytogenetic and proliferative potentials in meningiomas.

Debiec-Rychter M, Biernat W, Limon J, Kordek R, Izycka E, Borowska-Lehman J, Imieliński B, Liberski PP.

Pol J Pathol. 1999;50(4):243-8.

PMID:
10721264
13.

High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.

Holland H, Mocker K, Ahnert P, Kirsten H, Hantmann H, Koschny R, Bauer M, Schober R, Scholz M, Meixensberger J, Krupp W.

Cancer Genet. 2011 Oct;204(10):541-9. doi: 10.1016/j.cancergen.2011.10.007.

PMID:
22137484
14.

Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome.

Tabernero MD, Maillo A, Gil-Bellosta CJ, Castrillo A, Sousa P, Merino M, Orfao A.

Brain Pathol. 2009 Jul;19(3):409-20. doi: 10.1111/j.1750-3639.2008.00191.x. Epub 2008 Jul 15.

PMID:
18637901
15.

Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.

Sayagués JM, Tabernero MD, Maíllo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de Alava E, Garcia-Macias MC, Orfao A.

J Neuropathol Exp Neurol. 2006 May;65(5):445-54.

PMID:
16772868
16.

Cytogenetic studies in 50 meningiomas.

Maltby EL, Ironside JW, Battersby RD.

Cancer Genet Cytogenet. 1988 Apr;31(2):199-210.

PMID:
3162394
17.

Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.

Ishino S, Hashimoto N, Fushiki S, Date K, Mori T, Fujimoto M, Nakagawa Y, Ueda S, Abe T, Inazawa J.

Cancer. 1998 Jul 15;83(2):360-6.

PMID:
9669820
18.

[Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion].

López-Ginés C, Gil-Benso R, Collado-Díaz M, Gregori-Romero M, Roldán P, Barberá J, Cerdá-Nicolás M.

Neurocirugia (Astur). 2003 Dec;14(6):517-25. Spanish.

19.

Genetic changes with prognostic value in histologically benign meningiomas.

Barbera S, San Miguel T, Gil-Benso R, Muñoz-Hidalgo L, Roldan P, Gonzalez-Darder J, Cerda-Nicolas M, Lopez-Gines C.

Clin Neuropathol. 2013 Jul-Aug;32(4):311-7. doi: 10.5414/NP300580.

PMID:
23442303
20.

The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.

Espinosa AB, Tabernero MD, Maíllo A, Sayagués JM, Ciudad J, Merino M, Alguero MC, Lubombo AM, Sousa P, Santos-Briz A, Orfao A.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):772-80.

Supplemental Content

Support Center